Follow
Myron R. Szewczuk
Myron R. Szewczuk
Professor of Immunology
Verified email at queensu.ca - Homepage
Title
Cited by
Cited by
Year
Hapten-induced model of chronic inflammation and ulceration in the rat colon
GP Morris, PL Beck, MS Herridge, WT Depew, MR Szewczuk, JL Wallace
Gastroenterology 96 (2), 795-803, 1989
24901989
Current challenges in cancer immunotherapy: multimodal approaches to improve efficacy and patient response rates
M Sambi, L Bagheri, MR Szewczuk
Journal of oncology 2019 (1), 4508794, 2019
2802019
Impairment of host-versus-graft reaction in pregnant mice: II. Selective suppression of cytotoxic T-cell generation correlates with soluble suppressor activity and with …
DA Clark, MR McDermott, MR Szewczuk
Cellular Immunology 52 (1), 106-118, 1980
2621980
Recent advances in “smart” delivery systems for extended drug release in cancer therapy
RV Kalaydina, K Bajwa, B Qorri, A Decarlo, MR Szewczuk
International journal of nanomedicine, 4727-4745, 2018
2342018
Neu1 desialylation of sialyl α-2, 3-linked β-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling
SR Amith, P Jayanth, S Franchuk, T Finlay, V Seyrantepe, R Beyaert, ...
Cellular signalling 22 (2), 314-324, 2010
2302010
Dependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidase
SR Amith, P Jayanth, S Franchuk, S Siddiqui, V Seyrantepe, K Gee, ...
Glycoconjugate journal 26, 1197-1212, 2009
1572009
Enhanced Suppressor Cell Activity as a Mechanism of Immunosuppression by 2,3,7,8-Tetrachlorodibenzo-p-dioxin
DA Clark, J Gauldie, MR Szewczuk, G Sweeney
Proceedings of the Society for Experimental Biology and Medicine 168 (2 …, 1981
1461981
Non-nutritive sweeteners and their implications on the development of metabolic syndrome
I Liauchonak, B Qorri, F Dawoud, Y Riat, MR Szewczuk
Nutrients 11 (3), 644, 2019
1132019
Regulation of phagocytosis in macrophages by neuraminidase 1
V Seyrantepe, A Iannello, F Liang, E Kanshin, P Jayanth, S Samarani, ...
Journal of Biological Chemistry 285 (1), 206-215, 2010
1112010
Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for Toll-like receptor activation and cellular signaling
S Abdulkhalek, SR Amith, SL Franchuk, P Jayanth, M Guo, T Finlay, ...
Journal of Biological Chemistry 286 (42), 36532-36549, 2011
1102011
Loss of immune competence with age may be due to auto-anti-idiotypic antibody regulation
MR Szewczuk, RJ Campbell
Nature 286 (5769), 164-166, 1980
981980
A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes
F Alghamdi, M Guo, S Abdulkhalek, N Crawford, SR Amith, MR Szewczuk
Cellular Signalling 26 (6), 1355-1368, 2014
972014
A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer
AM Gilmour, S Abdulkhalek, TSW Cheng, F Alghamdi, P Jayanth, ...
Cellular signalling 25 (12), 2587-2603, 2013
892013
Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
Y Mouhamed, A Vishnyakov, B Qorri, M Sambi, SMS Frank, C Nowierski, ...
Drug, healthcare and patient safety, 45-66, 2018
832018
Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for neurotrophin activation of Trk receptors and cellular signaling
P Jayanth, SR Amith, K Gee, MR Szewczuk
Cellular signalling 22 (8), 1193-1205, 2010
772010
Aging, idiotype repertoire shifts, and compartmentalization of the mucosal-associated lymphoid system
AW Wade, MR Szewczuk
Advances in immunology 36, 143-188, 1984
771984
Lack of age-associated immune dysfunction in mucosal-associated lymph nodes.
MR Szewczuk, RJ Campbell, LK Jung
Journal of immunology (Baltimore, Md.: 1950) 126 (6), 2200-2204, 1981
761981
Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis
F Haxho, RJ Neufeld, MR Szewczuk
Oncotarget 7 (26), 40860, 2016
752016
Neu1 sialidase and matrix metalloproteinase-9 cross-talk regulates nucleic acid-induced endosomal TOLL-like receptor-7 and-9 activation, cellular signaling and pro-inflammatory …
S Abdulkhalek, MR Szewczuk
Cellular Signalling 25 (11), 2093-2105, 2013
732013
Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (TamifluŽ) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance
LK O’Shea, S Abdulkhalek, S Allison, RJ Neufeld, MR Szewczuk
OncoTargets and therapy, 117-134, 2014
712014
The system can't perform the operation now. Try again later.
Articles 1–20